|
Pathways that are overrepresented taking up-regulated genes into account
|
|
Integrin signaling pathway
|
185
|
19
|
3.48
|
4.78E-09
|
|
WNT signaling pathway
|
348
|
22
|
6.55
|
1.27E-06
|
|
Angiogenesis
|
193
|
12
|
3.63
|
3.76E-04
|
|
Cadherin signaling pathway
|
167
|
11
|
3.14
|
4.07E-04
|
|
Alzheimer disease-presenilin pathway
|
124
|
9
|
2.33
|
6.84E-04
|
|
Pathways that are overrepresented taking downregulated genes into account
|
|
B cell activation
|
87
|
21
|
3.01
|
1.03E-11
|
|
p53 pathway
|
127
|
18
|
4.39
|
8.32E-07
|
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
298
|
29
|
10.30
|
1.12E-06
|
|
Blood coagulation
|
55
|
10
|
1.90
|
2.96E-05
|
|
p53 pathway feedback loops 2
|
51
|
9
|
1.76
|
9.15E-05
|
|
Parkinson disease
|
106
|
13
|
3.66
|
1.13E-04
|
|
Cell cycle
|
24
|
6
|
0.83
|
2.21E-04
|
|
Integrin signaling pathway
|
185
|
17
|
6.39
|
3.38E-04
|
|
De novo pyrimidine deoxyribonucleotide biosynthesis
|
23
|
5
|
0.79
|
1.36E-03
|
|
DNA replication
|
25
|
5
|
0.86
|
1.95E-03
|
|
Ras Pathway
|
80
|
9
|
2.76
|
2.20E-03
|
|
Apoptosis signaling pathway
|
141
|
12
|
4.87
|
4.37E-03
|
|
T cell activation
|
142
|
12
|
4.91
|
4.61E-03
|
|
JAK/STAT signaling pathway
|
20
|
4
|
0.69
|
5.48E-03
|
|
Angiogenesis
|
193
|
14
|
6.67
|
8.51E-03
|
|
Pathways that are overrepresented taking up- and down-regulated genes into account
|
|
Integrin signaling pathway
|
185
|
36
|
9.87
|
7.87E-09
|
|
B cell activation
|
87
|
24
|
4.64
|
7.10E-09
|
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
298
|
41
|
15.90
|
2.42E-06
|
|
p53 pathway
|
127
|
21
|
6.78
|
1.79E-04
|
|
Angiogenesis
|
193
|
26
|
10.30
|
4.45E-04
|
|
Blood coagulation
|
55
|
12
|
2.93
|
8.00E-04
|
|
p53 pathway feedback loops 2
|
51
|
9
|
2.72
|
2.42E-02
|
|
Cell cycle
|
24
|
6
|
1.28
|
2.19E-02
|
|
WNT signaling pathway
|
348
|
31
|
18.57
|
4.57E-02
|
|
Axon guidance mediated by netrin
|
29
|
6
|
1.55
|
4.36E-02
|
|
Parkinson disease
|
106
|
13
|
5.66
|
4.22E-02
|
